Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.80
Bid: 3.80
Ask: 3.84
Change: 0.09 (2.43%)
Spread: 0.04 (1.053%)
Open: 3.80
High: 3.80
Low: 3.80
Prev. Close: 3.71
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3G Peptide Technology Platform shows major promise

27 Oct 2014 07:00

RNS Number : 3065V
Plant Health Care PLC
27 October 2014
 

October 27, 2014

 

PLANT HEALTH CARE plc

 

Innatus™ 3G Peptide Technology Platform shows Major Promise

 

Plant Health Care (AIM: PHC), a leading provider of scientifically proven biological products for the agricultural industry, reports exciting results from its research on "third generation" peptide technology. Building on over twenty years of leadership and expertise in the area of protein-based biological products, the Company has developed Innatus™, a technology platform that enables the design, production and screening of a large pipeline of peptides with diverse biostimulant properties.

Under the leadership of Plant Health Care's Chief Science Officer, Dr. Zhongmin Wei, this groundbreaking work is being conducted at recently expanded research facilities in Seattle, WA.

Plant Health Care has initiated discussions with a number of industry players regarding the testing and evaluation of this technology.

Paul Schmidt, CEO at PHC stated, "This provides a platform from which to create an entire pipeline of diverse and proprietary peptides which act as powerful biostimulants via both seed treatment and foliar applications. Most exciting is the ability to design and customize peptides to achieve specificity by crop and desired biological response. And the ability to combine these peptides with conventional crop protection chemicals makes them highly complementary to existing production practices.

"The pipeline is showing promise in delivering a range of benefits for farmers, including drought tolerance, disease resistance and increased yield. We plan to engage with those parties that have the development and commercialization capabilities to exploit the full potential of this platform."

 

 

~ End ~

 

 

For further information please contact:

 

Plant Health Care, plc

Paul Schmidt, Chief Executive Officer

Tel: +1-919-926-1600

Jeff Hovey, Finance Director

Liberum Capital Limited

Tel: +44 (0) 20 3100 2000

Clayton Bush/ Steven Tredget

Powerscourt

Tel: +44 (0) 20 7250 1446

Sophie Moate / Tessa Berry

 

 

About Plant Health Care, plc: Plant Health Care, plc ("PHC") is a leading provider of scientifically proven biological products for the agricultural industry. The Company's ordinary shares have been quoted on the Alternative Investment Market ("AIM") of the London Stock Exchange since July 2004. The Company offers products to improve the health, vigor and yield of major field crops such as corn, soybeans, cotton and rice, as well as specialty crops such as fruits and vegetables. PHC's innovative line of patent protected products provides both economic and environmental benefits for customers and capitalizes upon long-term trends towards natural systems and biological solutions to promote plant health and growth. Plant Health Care has global reach through operating subsidiaries and supply agreements with major industry partners. For more information, please visit www.planthealthcare.com 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAKMMZGKVKGDZM
Date   Source Headline
22nd Apr 20247:00 amRNSApproval of Harpinαβ in Belgium
16th Apr 20247:00 amRNSPlant Health Care--China Distribution with AMVAC
4th Apr 20247:00 amRNSApproval of PHC68949 in Mexico
4th Mar 20241:55 pmRNSHolding(s) in Company
24th Jan 20244:27 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBrazil approves TEIKKOâ„¢
20th Dec 20237:00 amRNSBoard Changes and Grant of Options
19th Dec 20233:34 pmRNSHolding(s) in Company
30th Nov 20231:45 pmRNSHolding(s) in Company
28th Nov 20233:16 pmRNSHolding(s) in Company
27th Nov 20234:03 pmRNSHolding(s) in Company
27th Nov 20231:27 pmRNSHolding(s) in Company
24th Nov 20234:19 pmRNSDirector/PDMR Shareholding
24th Nov 202310:57 amRNSDirector/PDMR Shareholding
23rd Nov 20232:31 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSChange of Adviser
20th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20236:28 pmRNSPlant Health Care PREtec Product with Agrii UK
28th Sep 20237:00 amRNSNew PREtec Products Announced
27th Sep 20237:00 amRNSUnaudited Interim Results
25th Sep 20237:00 amRNSPREtec Products Submitted for Regulatory Approval
31st Aug 20237:00 amRNSNotice of Results & Investor Presentation
18th Aug 20237:00 amRNSNew Product Regulatory Approval In Brazil
1st Aug 20237:00 amRNSApproval for Sale of Harpin aß Granted in Poland
24th Jul 20237:00 amRNSGrant of Options
12th Jul 202312:27 pmRNSHolding(s) in Company
30th Jun 20235:07 pmRNSNotification of Major Holdings
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement
30th Jan 202312:08 pmRNSSignificant Shareholder
18th Jan 20237:00 amRNSBoard Appointments
12th Jan 20237:00 amRNSNovozymes Distribution Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.